[Caixin Global] Brand-name drugs feel the squeeze in China’s generic-heavy market
Multinational pharmaceutical firms are changing strategies and selling business lines, as a government bulk-buying program favors cheaper, local products.
Click here to read the article by Tang Hanyu and Kelly Wang.
Narrated by Elyse Ribbons.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Create your
podcast in
minutes
It is Free